Tamoxifen: a most unlikely pioneering medicine
By V. Jordan. Nature reviews. Drug discovery, 2003
784 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Pharmacology
View Paper: https://www.semanticscholar.org/paper/57a01a9684892b21008fbf9c873ed6adcecc944a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
Citations in the corpus
- DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network (2016, background): “commendation population is 40:099and 31:770months, respectively. The majority of patients were recommended to undergo hormone therapy (tamoxifen), which is in alignment with standard medical practice [35]. 0 10 20 30 40 50 60 70 80 Timeline (months) 0.0 0.2 0.4 0.6 0.8 1.0 Percent of Poplation Alive”